FDA Withdraws Approval For Drug Touted By Trump

The Washington Post reports:

The Food and Drug Administration has withdrawn its emergency use authorization for hydroxychloroquine to treat coronavirus patients. President Trump had repeatedly promoted the antimalarial drug as a way to prevent or treat covid-19.

The agency said Monday in a statement that “it is no longer reasonable to believe” the drug may be effective against covid-19 or that its benefits outweigh “known and potential risks.”

The move comes after months of questions and criticisms about the FDA’s authorization of the product, which can cause potential heart-rhythm problems.

America: Do not listen to President Trump on any medical advice.

His own FDA is rejecting his advice on hydroxychloroquine.

On medical issues like on so much else, he doesn’t know what he’s talking about.https://t.co/9CXZWnyV5f

— Chuck Schumer (@SenSchumer) June 15, 2020